{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:23:40Z","timestamp":1776684220725,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["P01HS021141"],"award-info":[{"award-number":["P01HS021141"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Heart, Lung, and Blood Institute of the National Institutes of Health","award":["T32 HL069771"],"award-info":[{"award-number":["T32 HL069771"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ypmed.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T20:33:41Z","timestamp":1460838821000},"page":"176-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers"],"prefix":"10.1016","volume":"88","author":[{"given":"Kunal N.","family":"Karmali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Persell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ypmed.2016.04.011_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/pubmed\/fdl068","article-title":"Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and outcomes Framework'","volume":"29","author":"Ashworth","year":"2007","journal-title":"J Public Health (Oxf.)"},{"issue":"2","key":"10.1016\/j.ypmed.2016.04.011_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1751-7141.2008.00019.x","article-title":"Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk","volume":"12","author":"Barham","year":"2009","journal-title":"Prev. Cardiol."},{"key":"10.1016\/j.ypmed.2016.04.011_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2840-8-25","article-title":"Patterns and predictors of statin prescription in patients with type 2 diabetes","volume":"8","author":"Berthold","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.ypmed.2016.04.011_bb0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archinternmed.2009.44","article-title":"Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial","volume":"169","author":"Bertoni","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"10.1016\/j.ypmed.2016.04.011_bb0025","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/hrt.2006.087932","article-title":"Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review","volume":"92","author":"Brindle","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ypmed.2016.04.011_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2377-14-53","article-title":"Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry","volume":"14","author":"Canavero","year":"2014","journal-title":"BMC Neurol."},{"issue":"9841","key":"10.1016\/j.ypmed.2016.04.011_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists","year":"2012","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ypmed.2016.04.011_bb0040","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1001\/jama.286.14.1732","article-title":"Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease","volume":"286","author":"Federman","year":"2001","journal-title":"J. Am. Med. Assoc."},{"issue":"24","key":"10.1016\/j.ypmed.2016.04.011_bb0045","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/CIRCULATIONAHA.113.007595","article-title":"Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility","volume":"129","author":"Fontana","year":"2014","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"10.1016\/j.ypmed.2016.04.011_bb0050","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ypmed.2016.04.011_bb0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ypmed.2016.04.011_bb0060","doi-asserted-by":"crossref","first-page":"e004812","DOI":"10.1136\/bmjopen-2014-004812","article-title":"General practitioners' use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study","volume":"4","author":"Jansen","year":"2014","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.ypmed.2016.04.011_bb0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jacc.2014.06.1186","article-title":"A systematic examination of the 2013 ACC\/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease","volume":"64","author":"Karmali","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ypmed.2016.04.011_bb0070","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jtcvs.2007.05.039","article-title":"Patterns and predictors of statin use after coronary artery bypass graft surgery","volume":"134","author":"Kulik","year":"2007","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.ypmed.2016.04.011_bb0075","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/CIRCULATIONAHA.108.835470","article-title":"Systematic examination of the updated Framingham heart study general cardiovascular risk profile","volume":"120","author":"Marma","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ypmed.2016.04.011_bb0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0272989X12437246","article-title":"Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment","volume":"32","author":"Mohammed","year":"2012","journal-title":"Med. Decis. Mak."},{"issue":"4","key":"10.1016\/j.ypmed.2016.04.011_bb0085","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics-2015 update: a report from the american heart association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ypmed.2016.04.011_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF03405430","article-title":"Statin use in Canadians: trends, determinants and persistence","volume":"98","author":"Neutel","year":"2007","journal-title":"Can. J. Public Health"},{"issue":"4","key":"10.1016\/j.ypmed.2016.04.011_bb0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s11606-012-2268-1","article-title":"Electronic health record-based patient identification and individualized mailed outreach for primary cardiovascular disease prevention: a cluster randomized trial","volume":"28","author":"Persell","year":"2013","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.ypmed.2016.04.011_bb0100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCOUTCOMES.115.001723","article-title":"Individualized risk communication and outreach for primary cardiovascular disease prevention in community health centers: randomized trial","volume":"8","author":"Persell","year":"2015","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ypmed.2016.04.011_bb0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1472-6963-8-60","article-title":"Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature","volume":"8","author":"Sheridan","year":"2008","journal-title":"BMC Health Serv. Res."},{"issue":"3","key":"10.1016\/j.ypmed.2016.04.011_bb0110","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archinternmed.2009.516","article-title":"The effect of giving global coronary risk information to adults: a systematic review","volume":"170","author":"Sheridan","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"25 Suppl 2","key":"10.1016\/j.ypmed.2016.04.011_bb0115","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ypmed.2016.04.011_bb0120","first-page":"Cd004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"25","key":"10.1016\/j.ypmed.2016.04.011_bb0125","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ypmed.2016.04.011_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2013.10.002","article-title":"Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial","volume":"167","author":"Vagholkar","year":"2014","journal-title":"Am. Heart J."},{"issue":"18","key":"10.1016\/j.ypmed.2016.04.011_bb0135","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743516300664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743516300664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T19:46:10Z","timestamp":1600458370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743516300664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":27,"alternative-id":["S0091743516300664"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2016.04.011","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}